ArticleIndian journal of palliative care
Managing Pregabalin Misuse in Clinical Practice: A Growing Concern in Pain, Palliative and Anaesthesia Care.
Article in Indian journal of palliative care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregabalin is an essential pharmacological aid in pain and palliative care practice. Its use has significantly improved pain control, both for acute and chronic conditions, when helping to reduce the need for opioids. Despite these benefits, the misuse of pregabalin has become a serious issue. The reasons cited by patients for pregabalin use included reduced opioid cravings, sedation, euphoria, relief from opioid withdrawal symptoms and anxiety relief. Stringent steps should be taken to address the misuse of pregabalin while ensuring that it remains a useful therapeutic tool. To ensure that pregabalin remains effective for patients without exacerbating the substance misuse problem, it is important to enhance regulations, boost patient education and establish thorough prescribing and monitoring practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.